Search
Returning search results with filters:
Remove filter for
Category: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 15 of 446 items.
Unauthorized health products seized from online retailer “UU Zone” may pose serious health risks
Health Canada is warning consumers about unauthorized health products it seized from UU Zone, an online retailer, based in Markham, ON. The products are labelled to contain medicinal drugs and may pose serious health risks.
Selling unauthorized health…
AlertPublic advisory | 2024-03-13
Unauthorized health products seized from Tokyo Beauty and Healthcare store in Richmond, B.C., may pose serious health risks
UPDATE: March 8, 2024: Additional unauthorized health products seized from another Tokyo Beauty and Healthcare store in Richmond, B.C.
Further to its communication on September 18, 2023, Health Canada is warning consumers about additional unauthorized…
AlertPublic advisory | 2024-03-08
Unauthorized sexual enhancement products may pose serious health risks
Health Canada is advising about unauthorized sexual enhancement products that may pose serious health risks. The products are labelled to contain or have been tested and found to contain dangerous ingredients. Health Canada updates the table when it…
AlertPublic advisory | 2024-03-01
Counterfeit erectile dysfunction drugs seized from two convenience stores in Toronto
Health Canada has seized counterfeit Viagra from a Daisy Mart in Toronto, as well as counterfeit Viagra and Cialis from an MJ Mini Mart in Toronto. The counterfeit products were sold in individual blister packs with no other packaging. Authorized Viagra…
AlertPublic advisory | 2024-02-28
Paclitaxel-Coated Balloons (PCB) and Paclitaxel-Eluting Stents (PES) for the Treatment of Peripheral Arterial Disease (PAD) and the Potential Risk of Long-Term All-Cause Mortality
UPDATED INFORMATION – February 20, 2024
Health Canada worked with manufacturers, clinicians, and other international health regulatory agencies to further assess the risk of increased mortality associated with the use of paclitaxel-coated devices…
AlertHealth professional risk communication | 2024-02-20
Audrina 28 birth control pills: Day-of-the-week stickers in some lots have a misprint that could lead to confusion around dosing
Certain lots of Audrina 28 birth control pills contain day-of-the-week stickers that have a misprint that could lead to confusion around when to take the medication.
Audrina 28 is a prescription drug used to prevent pregnancy and treat moderate acne in…
AlertPublic advisory | 2024-02-20
APO-Mometasone nasal spray: Two lots recalled due to possible risk of infection
Apotex Inc. is recalling two lots of APO-Mometasone nasal spray due to possible bacterial contamination with Burkholderia cepacia complex (Bcc). Bcc is a group of bacteria that poses a low medical risk to most healthy people; however, children, those…
AlertPublic advisory | 2024-02-19
Pediatrix Acetaminophen Oral Solution for children: One lot recalled due to potential risk of overdose
Teva Canada Ltd. is recalling one lot of Pediatrix Acetaminophen Oral Solution after routine product testing found a higher than acceptable amount of acetaminophen in the affected lot (approximately 185mg/5mL rather than the approved and labelled 160mg/…
AlertPublic advisory | 2024-01-17
Unauthorized skin lightening and skin treatment products may pose serious health risks
Health Canada is advising about unauthorized health products for lightening skin or treating skin conditions (such as eczema or psoriasis) that may pose serious health risks. The products are labelled to contain or have been tested and found to…
AlertPublic advisory | 2023-12-27
JAMP Guanfacine XR 1 mg tablets: One lot recalled as some bottles may also contain higher strength tablets
JAMP Pharma Corporation is recalling one lot of JAMP Guanfacine extended release (XR) 1 mg tablets because some bottles may contain JAMP Guanfacine XR 4 mg tablets in addition to the correct strength of 1 mg tablets. Patients taking a 4 mg tablet…
AlertPublic advisory | 2023-12-14
Unauthorized workout supplements may pose serious health risks
Health Canada is advising about unauthorized workout products that may pose serious health risks. The products are labelled to contain or have been tested and found to contain dangerous ingredients. Health Canada updates the table when it finds…
AlertPublic advisory | 2023-12-13
Unauthorized injectable drug products sold online by Canlab Research may pose serious health risks
Health Canada is warning consumers not to buy unauthorized injectable drug products from Canlab Research because they may pose serious health risks. The products are promoted as peptides and are sold online via Canlab Research websites including www.…
AlertPublic advisory | 2023-12-13
Unauthorized blood glucose (sugar)-reading smartwatches may pose serious health risks to people with diabetes
Health Canada is warning people with diabetes and parents/caregivers of people with diabetes that various social media and online retail platforms are promoting unauthorized blood glucose-reading smartwatches. These devices have not been assessed for…
AlertPublic advisory | 2023-11-29
Donepezil 10 mg tablets: One lot recalled due to possible oversized tablets
Pro Doc Limitée is recalling one lot of Donepezil (donepezil hydrochloride) 10 mg tablets due to the possibility that some bottles might contain oversized tablets. Health Canada is warning patients and their caregivers that taking an oversized…
AlertPublic advisory | 2023-11-24
Shortage of Nitroglycerin Sprays and Tablets in Canada
UPDATE: November 10, 2023 – Extended Shortage of Mylan’s Nitroglycerin Spray
Mylan is reporting ongoing supply issues with an unknown resolution date for its shortage of nitroglycerin 0.4 MG/ACT spray.
Health Canada, together with its partners, is…
AlertPublic advisory | 2023-11-10